Evidence map›Paper›PMID 38755527›Full record

ArticleBMC bioinformatics2024

AMRViz enables seamless genomics analysis and visualization of antimicrobial resistance.

Duc Quang Le, Son Hoang Nguyen, Tam Thi Nguyen, Canh Hao Nguyen, Tho Huu Ho, Nam S Vo, Trang Nguyen, Hoang Anh Nguyen, Minh Duc Cao

Abstract read
In one paragraph

Article in BMC bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. FTIR typing of the emerging NDM-14-producingJournal of clinical microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Duc Quang LeAMROMICS JSC, Nghe An, Vietnam. quangld@huce.edu.vn.
Son Hoang NguyenAMROMICS JSC, Nghe An, Vietnam. dr.sonhoangnguyen@gmail.com.
Tam Thi NguyenOxford University Clinical Research Unit, Hanoi, Vietnam.
Canh Hao NguyenBioinformatics Center, Institute for Chemical Research, Kyoto University, Kyoto, Japan.
Tho Huu HoDepartment of Medical Microbiology, The 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.
Nam S VoCenter for Biomedical Informatics, Vingroup Big Data Institute, Hanoi, Vietnam.
Trang NguyenAMROMICS JSC, Nghe An, Vietnam.
Hoang Anh NguyenAMROMICS JSC, Nghe An, Vietnam.
Minh Duc CaoAMROMICS JSC, Nghe An, Vietnam. minhduc.cao@gmail.com.

Funding

Vingroup Innovation Foundation (VINIF) VINIF.2019.DA11
6 · The paper itself

Abstract

We have developed AMRViz, a toolkit for analyzing, visualizing, and managing bacterial genomics samples. The toolkit is bundled with the current best practice analysis pipeline allowing researchers to perform comprehensive analysis of a collection of samples directly from raw sequencing data with a single command line. The analysis results in a report showing the genome structure, genome annotations, antibiotic resistance and virulence profile for each sample. The pan-genome of all samples of the collection is analyzed to identify core- and accessory-genes. Phylogenies of the whole genome as well as all gene clusters are also generated. The toolkit provides a web-based visualization dashboard allowing researchers to interactively examine various aspects of the analysis results. Availability: AMRViz is implemented in Python and NodeJS, and is publicly available under open source MIT license at https://github.com/amromics/amrviz .

Indexed as

Genome, BacterialGenomicsSoftwareAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialPhylogenyAnti-Bacterial AgentsAntimicrobial resistanceMicrobial genomicsVisualization

Identifiers

PMID38755527
PMCPMC11100100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.